Kardiyovasküler Hastalık Riski ve Majör Depresyonun İlişkisi

Amaç: Depresyondaki kardiyovasküler risk, küçük klinik örneklemlerde ve toplum temelli çalışmalarda araştırılmış ve çelişkili sonuçlar elde edilmiştir. Bununla birlikte, hiç antidepresan kullanmamış depresif hastalarda kardiyovasküler risk kapsamlı bir şekilde test edilmemiştir. Yöntem: Vücut kitle indeksine dayalı Framingham Kardiyovasküler Risk Skoru ve çözünür hücreler arası adezyon molekülü-1 (sICAM-1) seviyeleri, ilaç kullanmayan depresif hastalarda ve sağlıklı gönüllülerde kardiyovasküler hastalık riskini değerlendirmek için kullanılmıştır. Bulgular: Framingham Kardiyovasküler Risk Skorlarında ve tek tek değerlendirilen risk faktörlerinde hastalar ve sağlıklı kontroller arasında anlamlı fark yoktu. Her iki grup da sICAM-1 açısından benzerdi. Sonuç: Kardiyovasküler risk ile majör depresyon arasında yaygın olarak saptanan ilişki, ileri yaşlardaki depresif hastalarda ve tekrarlayan atakları olan hastalarda daha belirgin olabilir.

Anahtar Kelime:

The Relationship Between Cardiovascular Disease Risk and Major Depression

Öz:

Introduction: Cardiovascular risk in depression has been investigated in small clinical samples and population-based studies revealing inconclusive results. However, cardiovascular risk in drug-naive depressed patients has not been tested extensively. Methods: Body mass index-based Framingham Cardiovascular Risk Scores and soluble intercellular adhesion molecule-1 (sICAM-1) levels were used to assess the risk of cardiovascular disease in drug-naive depressed patients and healthy volunteers. Conclusion: There were no significant differences in Framingham Cardiovascular Risk Scores and individually assessed risk variables between patients and healthy controls. Both groups were comparable in terms of sICAM-1. Results: The widely recognized association between cardiovascular risk and major depression might be more prominent in older depressed patients and patients with recurring episodes.

Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Bibliyografik

1. Alexopoulos GS. Depression and cerebrovascular disease: what is to be done? Am J Geriatr Psychiatry. 2017;25:129–130. [Crossref]
2. Halaris A. Inflammation-associated co-morbidity between depression and cardiovascular disease. Curr Top Behav Neurosci. 2017;31:45–70. [Crossref]
3. Penninx BW, Beekman AT, Honig A, Deeg DJ, Schoevers RA, van Eijk JT, et al. Depression and cardiac mortality: results from a community-based longitudinal study. Arch Gen Psychiatry. 2001;58:221–227. [Crossref]
4. Salaycik KJ, Kelly-Hayes M, Beiser A, Nguyen AH, Brady SM, Kase CS, et al. Depressive symptoms and risk of stroke: the Framingham Study. Stroke. 2007;38:16–21. [Crossref]
5. Taylor WD, Aizenstein HJ, Alexopoulos GS. The vascular depression hypothesis: mechanisms linking vascular disease with depression. Mol Psychiatry. 2013;18:963–974. [Crossref]
6. Paz-Filho G, Licinio J, Wong M-L. Pathophysiological basis of cardiovascular disease and depression: a chicken-and-egg dilemma. Braz J Psychiatry. 2010;32:181–191. [Crossref]
7. Penninx BW. Depression and cardiovascular disease: Epidemiological evidence on their linking mechanisms. Neurosci Biobehav Rev. 2017;74:277– 286. [Crossref]
8. Müller N. The role of intercellular adhesion molecule-1 in the pathogenesis of psychiatric disorders. Front Pharmacol. 2019;10:1251. [Crossref]
9. Geraets AFJ, van Agtmaal MJM, Stehouwer CDA, Sörensen BM, Berendschot TTJM, Webers CAB, et al. Association of markers of microvascular dysfunction with prevalent and incident depressive symptoms: the Maastricht study. Hypertension. 2020;76:342–349. [Crossref]
10. van Agtmaal MJM, Houben AJHM, Pouwer F, Stehouwer CDA, Schram MT. Association of microvascular dysfunction with late-life depression: a systematic review and meta-analysis. JAMA Psychiatry. 2017;74:729–739. [Crossref]
11. Baghai TC, Varallo-Bedarida G, Born C, Häfner S, Schüle C, Eser D, et al. Classical risk factors and inflammatory biomarkers: one of the missing biological links between cardiovascular disease and major depressive disorder. Int J Mol Sci. 2018;19:1740. [Crossref]
12. Ivković M, Pantović-Stefanović M, Petronijević N, Dunjić-Kostić B, Velimirović M, Nikolić T, et al. Predictive value of sICAM-1 and sVCAM-1 as biomarkers of affective temperaments in healthy young adults. J Affect Disord. 2017;207:47–52.
13. Williams JBW, Link MJ, Rothenthal NE, Terman M. Structured Interview Guide for the Hamilton Depression Rating Scale, Seasonal Affective Disorder Version (SIGH-SAD). New York: New York Psychiatric Institute; 1992. https:// eprovide.mapi-trust.org/instruments/structured-interview-guide-for-the- hamilton-depression-rating-scale-seasonal-affective-disorders
14. Aydemir Ö, Deveci A, İçelli İ. Hamilton depresyonu derecelendirme ölçeği yapılandırılmış görüşme kılavuzu mevsimsel duygudurum bozukluğu versiyonunun güvenilirlik ve geçerliliği. Türkiye’de Psikiyatri. 2006;8:18–22.
15. First M, Gibbon M, Spitzer RL, Williams JBW, Benjamin LS. Structured clinical interview for DSM-IV II personality disorders (SCID-II). Washington, DC: American Psychiatric Press, Inc; 1997.
16. Özkürkçügil A, Aydemir Ö, Yıldız M, Esen Danacı A. DSM-IV eksen I bozuklukları için yapılandırılmış klinik görüşmenin Türkçe’ye uyarlanması ve güvenilirlik çalışması. İlaç ve Tedavi Derg. 1999;12:233–236.
17. D’Agostino Sr RB, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008;117:743–753. [Crossref]
18. Jones CA, Ross L, Surani N, Dharamshi N, Karmali K. Framingham ten-year general cardiovascular disease risk: agreement between BMI-based and cholesterol-based estimates in a South Asian convenience sample. PLoS One. 2015;10:e0119183. [Crossref]
19. Van der Kooy K, van Hout H, Marwijk H, Marten H, Stehouwer C, Beekman A. Depression and the risk for cardiovascular diseases: systematic review and meta analysis. Int J Geriatr Psychiatry. 2007;22:613–626. [Crossref]
20. Agatisa PK, Matthews KA, Bromberger JT, Edmundowicz D, Chang YF, Sutton- Tyrrell K. Coronary and aortic calcification in women with a history of major depression. Arch Intern Med. 2005;165:1229–1236. [Crossref]
21. Jones DJ, Bromberger JT, Sutton-Tyrrell K, Matthews KA. Lifetime history of depression and carotid atherosclerosis in middle- aged women. Arch Gen Psychiatry. 2003;60:153–160. [Crossref]
22. Matthews KA, Chang Y-F, Sutton-Tyrrell K, Edmundowicz D, Bromberger JT. Recurrent major depression predicts progression of coronary calcification in healthy women: study of women’s health across the nation. Psychosom Med. 2010;72:742–747. [Crossref]
23. Herbst S, Pietrzak RH, Wagner J, White WB, Petry NM. Lifetime major depression is associated with coronary heart disease in older adults: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Psychosom Med. 2007;69:729–734. [Crossref]
24. Sneed JR, Roose SP, Sackeim HA. Vascular depression: a distinct diagnostic subtype? Biol Psychiatry. 2006;60:1295–1298. [Crossref]
25. Baune BT, Stuart M, Gilmour A, Wersching H, Arolt V, Berger K. Moderators of the relationship between depression and cardiovascular disorders: a systematic review. Gen Hosp Psychiatry. 2012;34:478–492. [Crossref]
26. Wulsin LR, Evans JC, Vasan RS, Murabito JM, Kelly-Hayes M, Benjamin EJ. Depressive symptoms, coronary heart disease, and overall mortality in the Framingham Heart Study. Psychosom Med. 2005;67:697–702. [Crossref]
27. Lasserre AM, Glaus J, Vandeleur CL, Marques-Vidal P, Vaucher J, Bastardot F, et al. Depression with atypical features and increase in obesity, body mass index, waist circumference, and fat mass: a prospective, population-based study. JAMA Psychiatry. 2014;71:880–888. [Crossref]
28. Lasserre AM, Strippoli MF, Glaus J, Gholam-Rezaee M, Vandeleur CL, Castelao E, et al. Prospective associations of depression subtypes with cardio-metabolic risk factors in the general population. Mol Psychiatry. 2017;22:1026–1034. [Crossref]
29. Schlendorf KH, Nasir K, Blumenthal RS. Limitations of the Framingham risk score are now much clearer. Prev Med. 2009;48:115–116. [Crossref]
30. Michos ED, Nasir K, Braunstein JB, Rumberger JA, Budoff MJ, Post WS, et al. Framingham risk equation underestimates subclinical atherosclerosis risk in asymptomatic women. Atherosclerosis. 2006;184:201–206. [Crossref]
31. Pollin IS, Kral BG, Shattuck T, Sadler MD, Boyle JR, McKillop L, et al. High prevalence of cardiometabolic risk factors in women considered low risk by traditional risk assessment. J Womens Health (Larchmt). 2008;17:947–953. [Crossref]
32. Onat A, Uğur M, Tuncer M, Ayhan E, Kaya Z, Küçükdurmaz Z, et al. Age at death in the Turkish Adult Risk Factor Study: temporal trend and regional distribution at 56,700 person-years’ follow-up. Turk Kardiyol Dern Ars. 2009;37:155–160.
33. Stoner L, Lucero AA, Palmer BR, Jones LM, Young JM, Faulkner J. Inflammatory biomarkers for predicting cardiovascular disease. Clin Biochem. 2013;46:1353–1371. [Crossref]

APA	Targitay Ozturk B, Özel F, yaraş T, Ekinci B, Oktay Y, Onur Aysevener B, Alkın T, Direk N (2023). Kardiyovasküler Hastalık Riski ve Majör Depresyonun İlişkisi. , 124 - 128. 10.29399/npa.28191
Chicago	Targitay Ozturk Bilge,Özel Fatih,yaraş Tutku,Ekinci Burcu,Oktay Yavuz,Onur Aysevener Behice Elif,Alkın Tunç,Direk Nese Kardiyovasküler Hastalık Riski ve Majör Depresyonun İlişkisi. (2023): 124 - 128. 10.29399/npa.28191
MLA	Targitay Ozturk Bilge,Özel Fatih,yaraş Tutku,Ekinci Burcu,Oktay Yavuz,Onur Aysevener Behice Elif,Alkın Tunç,Direk Nese Kardiyovasküler Hastalık Riski ve Majör Depresyonun İlişkisi. , 2023, ss.124 - 128. 10.29399/npa.28191
AMA	Targitay Ozturk B,Özel F,yaraş T,Ekinci B,Oktay Y,Onur Aysevener B,Alkın T,Direk N Kardiyovasküler Hastalık Riski ve Majör Depresyonun İlişkisi. . 2023; 124 - 128. 10.29399/npa.28191
Vancouver	Targitay Ozturk B,Özel F,yaraş T,Ekinci B,Oktay Y,Onur Aysevener B,Alkın T,Direk N Kardiyovasküler Hastalık Riski ve Majör Depresyonun İlişkisi. . 2023; 124 - 128. 10.29399/npa.28191
IEEE	Targitay Ozturk B,Özel F,yaraş T,Ekinci B,Oktay Y,Onur Aysevener B,Alkın T,Direk N "Kardiyovasküler Hastalık Riski ve Majör Depresyonun İlişkisi." , ss.124 - 128, 2023. 10.29399/npa.28191
ISNAD	Targitay Ozturk, Bilge vd. "Kardiyovasküler Hastalık Riski ve Majör Depresyonun İlişkisi". (2023), 124-128. https://doi.org/10.29399/npa.28191

APA	Targitay Ozturk B, Özel F, yaraş T, Ekinci B, Oktay Y, Onur Aysevener B, Alkın T, Direk N (2023). Kardiyovasküler Hastalık Riski ve Majör Depresyonun İlişkisi. Nöropsikiyatri Arşivi, 60(2), 124 - 128. 10.29399/npa.28191
Chicago	Targitay Ozturk Bilge,Özel Fatih,yaraş Tutku,Ekinci Burcu,Oktay Yavuz,Onur Aysevener Behice Elif,Alkın Tunç,Direk Nese Kardiyovasküler Hastalık Riski ve Majör Depresyonun İlişkisi. Nöropsikiyatri Arşivi 60, no.2 (2023): 124 - 128. 10.29399/npa.28191
MLA	Targitay Ozturk Bilge,Özel Fatih,yaraş Tutku,Ekinci Burcu,Oktay Yavuz,Onur Aysevener Behice Elif,Alkın Tunç,Direk Nese Kardiyovasküler Hastalık Riski ve Majör Depresyonun İlişkisi. Nöropsikiyatri Arşivi, vol.60, no.2, 2023, ss.124 - 128. 10.29399/npa.28191
AMA	Targitay Ozturk B,Özel F,yaraş T,Ekinci B,Oktay Y,Onur Aysevener B,Alkın T,Direk N Kardiyovasküler Hastalık Riski ve Majör Depresyonun İlişkisi. Nöropsikiyatri Arşivi. 2023; 60(2): 124 - 128. 10.29399/npa.28191
Vancouver	Targitay Ozturk B,Özel F,yaraş T,Ekinci B,Oktay Y,Onur Aysevener B,Alkın T,Direk N Kardiyovasküler Hastalık Riski ve Majör Depresyonun İlişkisi. Nöropsikiyatri Arşivi. 2023; 60(2): 124 - 128. 10.29399/npa.28191
IEEE	Targitay Ozturk B,Özel F,yaraş T,Ekinci B,Oktay Y,Onur Aysevener B,Alkın T,Direk N "Kardiyovasküler Hastalık Riski ve Majör Depresyonun İlişkisi." Nöropsikiyatri Arşivi, 60, ss.124 - 128, 2023. 10.29399/npa.28191
ISNAD	Targitay Ozturk, Bilge vd. "Kardiyovasküler Hastalık Riski ve Majör Depresyonun İlişkisi". Nöropsikiyatri Arşivi 60/2 (2023), 124-128. https://doi.org/10.29399/npa.28191